Heat-induced "recall" of treatment zone erythema following fractional resurfacing with a combination laser (1320 nm/1440 nm)

Archives of Dermatology

Volumn 144, Issue 10, 2008, Pages 1398-1399

  Foster, K Wade ^b   Fincher, Edgar F ^b   Moy, Ronald L ^a  

^a Moy Fincher Medical Group   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; INTERLEUKIN 1ALPHA; PHOSPHOLIPASE A2; PROSTAGLANDIN SYNTHASE; SEROTONIN; TUMOR NECROSIS FACTOR;

ADULT; CASE REPORT; ERYTHEMA; FOREARM; HEAT; HUMAN; LASER; LETTER; MALE; MEDICAL TECHNOLOGY; NEODYMIUM LASER; PRIORITY JOURNAL; SKIN INJURY;

ADULT; ERYTHEMA; FOLLOW-UP STUDIES; HEAT; HUMANS; LASER THERAPY, LOW-LEVEL; LASERS; MALE; RECURRENCE; REMISSION, SPONTANEOUS; RISK ASSESSMENT; TIME FACTORS;

EID: 54349105408     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.144.10.1398     Document Type: Letter

References (4)

1. Halliday GM. Inflammation, gene mutation and photoimmunosuppression in response to UVR-induced oxidative damage contributes to photocarcinogenesis. Mutat Res. 2005;571(1-2):107-120.
2. Algermissen B, Hermes B, Henz BM, Muller U, Berlien HP. Laser-induced weal and flare reactions: clinical aspects and pharmacological modulation. Br J Dermatol. 2002;146(5):863-868.
3. Zeltser R, Valle L, Tanck C, Holyst MM, Ritchlin C, Gaspari AA. Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept: a recombinant tumor necrosis factor alpha receptor: Fc fusion protein. Arch Dermatol. 2001;137(7):893-899.
4. Geronemus RG. Fractional photothermolysis: current and future applications. Lasers Surg Med. 2006;38(3):169-176.